Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Metastatic Castration-resistant Prostate Cancer × cabazitaxel × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Neoplasms 2 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Metastatic Castration-resistant Prostate Cancer 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Carcinoma 1

Interventions

Prednisone 2 Pluvicto 2 sarilumab 1 rucaparib 1 ebastine 1 copanlisib 1 cemiplimab 1 cabazitaxel 1 afuresertib 1 Docetaxel 1 Clinical Trials, Phase I as Topic 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05340374 2025-04-06

LuCAB

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Active not recruiting

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡